This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

NeoDynamics 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Matilda Salen

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	n/a
경영진 평균 재임 기간	less than a year
이사회 평균 재임 기간	less than a year

최근 관리 업데이트

Recent updates

Is NeoDynamics (NGM:NEOD) In A Good Position To Invest In Growth?

Mar 18

NeoDynamics AB (publ) (NGM:NEOD) Insiders Increased Their Holdings

Dec 03

CEO

Matilda Salen

less than a year

테뉴어

Ms. Matilda Salen is Chief Executive Officer of NeoDynamics AB (publ) from March 2024. Matilda has a Bachelor's degree in Cognitive Neuroscience from Harvard University and has since been working as a mana...

리더십 팀

이름	위치	테뉴어	보상	소유권
Matthew Colpoys	US Country Manager & CEO and Director	1.1yrs	SEK 2.65m	데이터 없음
Matilda Salen	Chief Executive Officer	less than a year	데이터 없음	데이터 없음
Mats Gustafsson	CFO & Director	less than a year	데이터 없음	데이터 없음
Magnus Olsen	CDO & COO	3.5yrs	데이터 없음	0.012% SEK 3.4k

0.7yrs

평균 재임 기간

경험이 풍부한 관리: NEOD 의 관리팀은 경험 (평균 재직 기간 0.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Matthew Colpoys	US Country Manager & CEO and Director	3.5yrs	SEK 2.65m	데이터 없음
Mats Gustafsson	CFO & Director	less than a year	데이터 없음	데이터 없음
Erik Salén	Chairman of the Board	less than a year	데이터 없음	데이터 없음

0.5yrs

평균 재임 기간

경험이 풍부한 이사회: NEOD 의 이사회는 경험(평균 재직 기간 0.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

This company listing is no longer active

NeoDynamics 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Insufficient new directors

NeoDynamics AB (publ) Announces CFO Aaron Wong to Leave by End of May 2024

NeoDynamics Announces Changes to Board of Directors

NeoDynamics Appoints Matthew Colpoys, to Lead US Operations

NeoDynamics AB (publ) Appoints Brendan Carney as National Sales Director

Insider recently sold kr423k worth of stock

Recent updates

Nasdaq Stockholm AB Decides the Shares in NeoDynamics Shall Be Given Observation Status

First quarter 2024 earnings released: kr0.058 loss per share (vs kr19.28 loss in 1Q 2023)

Full year 2023 earnings released: kr30.21 loss per share (vs kr62.00 loss in FY 2022)

NeoDynamics AB (publ) to Report Nine Months, 2024 Results on Nov 19, 2024

Insufficient new directors

NeoDynamics AB (publ) Announces CFO Aaron Wong to Leave by End of May 2024

Neodynamics Launches Device Registry in Germany, Cost-Effective Collection of Real-World Data

New major risk - Shareholder dilution

NeoDynamics AB (publ) has completed a Composite Units Offering in the amount of SEK 72.30071 million.

Second quarter 2023 earnings released: kr0.22 loss per share (vs kr0.17 loss in 2Q 2022)

Neodynamics AB Presents Results of Pulse Study At the Annual Congress of the German Society of Senology, Munich

NeoDynamics AB Presents Final Data Set from NeoDynamics' Pulse Study Presented at the SBI Breast Imaging Symposium

Full year 2022 earnings released: kr0.76 loss per share (vs kr1.14 loss in FY 2021)

NeoDynamics AB (publ) to Report Fiscal Year 2023 Results on Feb 16, 2024

NeoDynamics Announces Changes to Board of Directors

NeoDynamics Appoints Matthew Colpoys, to Lead US Operations

Third quarter 2022 earnings released: kr0.12 loss per share (vs kr0.22 loss in 3Q 2021)

Price target decreased to kr1.10

NeoDynamics AB (publ) Appoints Brendan Carney as National Sales Director

Neodynamics AB (Publ) Launches Neonavia Biopsy System Configured with Its Flexipulse Probe in the United States to Support the Diagnosis of Cancer

NeoDynamics AB (publ) to Report Q3, 2022 Results on Nov 17, 2022

NeoDynamics Receives Approval for Its Innovative Pulse Biopsy System Neonavia® from the US Food and Drug Administration, FDA

Second quarter 2022 earnings released: kr0.17 loss per share (vs kr0.30 loss in 2Q 2021)

Neodynamics AB (Publ) Receives Ethical Approval for German Device Registry

Gryningskust Holding AB acquired additional 14.0 % minority stake in NeoDynamics AB (publ) (OM:NEOD).

NeoDynamics AB (publ) Announces Update on the FDA approval process for NeoNavia

First quarter 2022 earnings released: kr0.28 loss per share (vs kr0.29 loss in 1Q 2021)

NeoDynamics AB (publ) to Report Q1, 2022 Results on May 12, 2022

NeoDynamics Files a Registration Application for Its Innovative Pulse Biopsy System NeoNavia in the U.S

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

NeoDynamics AB (publ) to Report Fiscal Year 2021 Results on Feb 16, 2022

NeoDynamics AB to Present Results from the Pulse Study Illustrating the Benefits of the Novel Biopsy Device NeoNavia in Challenging Axillary Lymph Nodes, At the SBI/ACR Breast Imaging Symposium in Savannah, Georgia

Third quarter 2021 earnings released: kr0.22 loss per share (vs kr0.19 loss in 3Q 2020)

Neodynamics Grants A U.S. Patent for Its Biopsy Needle

Second quarter 2021 earnings released: kr0.30 loss per share (vs kr0.18 loss in 2Q 2020)

CFO & Head of Investor Relations Jorgen Vrenning has left the company

First quarter 2021 earnings released: kr0.29 loss per share (vs kr0.41 loss in 1Q 2020)

NeoDynamics AB Presents an Abstract on Pulse Biopsy Data for NeoNavia at the UK Association of Breast Surgeons Conference 2021

Is NeoDynamics (NGM:NEOD) In A Good Position To Invest In Growth?

New 90-day low: kr3.00

Full year 2020 earnings released: kr0.52 loss per share (vs kr1.24 loss in FY 2019)

New 90-day low: kr3.38

New 90-day low: kr3.60

NeoDynamics Will Be Granted Another European Patent for Its Pulse Biopsy Tools

New 90-day low: kr3.75

Insider recently sold kr423k worth of stock

NeoDynamics AB (publ) (NGM:NEOD) Insiders Increased Their Holdings

Third quarter 2020 earnings released: kr0.19 loss per share

NeoDynamics AB (Publ) Wins First UK Order of Pulse Biopsy System Neonavia

NeoDynamics AB (publ) Enters A Scientific Partnership to Evaluate Its Technology Platform in Osteoarthritis

NeoDynamics AB (publ) Announces Executive Changes

NeoDynamics AB (publ) Ready to Launch the New Pulse Biopsy System NeoNavia

New 90-day high - kr3.49

Earnings released

New 90-day high - kr3.37

CEO

테뉴어

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간